NDC 13107-070-25
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 2.5 mg/1
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate · TABLET
This is a prescription tablet containing a combination of amphetamine salts used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. It works by stimulating the central nervous system to improve focus, attention, and wakefulness.
Key Facts
- Brand Name
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
- Generic Name
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
- NDC Code (Package)
13107-070-25- NDC Code (Product)
13107-070- Manufacturer
- Aurolife Pharma, LLC
- Strength
- 2.5 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- ANDA202424
- Marketing Start
- 11/27/2013
Recall History
No Recall HistoryView Full Drug Page
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.